| 2024-04 |
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study |
Clinical Cancer Research
|
| 2024-01 |
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial |
Nature Communications
|
| 2024-01 |
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial |
Nature Communications
|
| 2024-01 |
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study |
Journal of Clinical Oncology
|
| 2024-01 |
First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine Against HER2-Positive Advanced Gastric Cancer |
Cancer Research and Treatment
|
| 2024-01 |
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study |
Gastric Cancer
|
| 2023-11 |
Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response |
Cell Reports Medicine
|
| 2023-10 |
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea |
Journal of Gastric Cancer
|
| 2023-09 |
Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy |
Yonsei Medical Journal
|
| 2023-09 |
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer |
Journal of Clinical Oncology
|
| 2023-04 |
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response |
Cancer Research and Treatment
|
| 2023-01 |
Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea |
Palliative Medicine Reports
|
| 2022-12 |
Therapeutic Implications of TGF-beta Pathway in Desmoid Tumor Based on Comprehensive Molecular Profiling and Clinicopathological Properties |
CANCERS
|
| 2022-10 |
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer |
NATURE COMMUNICATIONS
|
| 2022-10 |
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study |
Cancer Research and Treatment
|
| 2022-10 |
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors |
Investigational New Drugs
|
| 2022-09 |
Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer |
EUROPEAN JOURNAL OF CANCER
|
| 2022-08 |
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma |
CLINICAL CANCER RESEARCH
|
| 2022-07 |
PD-L1 expression and overall survival in Asian and western patients with gastric cancer |
FUTURE ONCOLOGY
|
| 2022-06 |
Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors |
Cancers
|
| 2022-05 |
Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin |
Cancers
|
| 2022-02 |
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer |
Nature Communications
|
| 2022-01 |
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group |
CANCER RESEARCH AND TREATMENT
|
| 2021-12 |
Prognostic significance of T-cell–inflamed gene expression profile and PD-L1 expression in patients with esophageal cancer |
CANCER MEDICINE
|
| 2021-10 |
Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial |
ESMO OPEN
|
| 2021-05 |
Detection of asymptomatic recurrence improves survival of gastric cancer patients |
CANCER MEDICINE
|
| 2021-04 |
Clinicopathological features of 70 desmoidt ype fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation anlysis |
PLOS ONE
|
| 2021-03 |
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma |
BMC CANCER
|
| 2021-03 |
Prognostic implications of PD-L1 expression in patients with angiosarcoma |
Future Science OA
|
| 2020-10 |
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma |
CANCER
|
| 2020-09 |
Comprehensive immuno-molecular profiles for liposarcoma: Roles of programmed death ligand 1, microsatellite instability, and pik3ca |
ONCOLOGY
|
| 2020-06 |
Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study |
TARGETED ONCOLOGY
|
| 2019-11 |
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer |
GASTRIC CANCER
|
| 2019-10 |
Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer |
Journal for ImmunoTherapy of Cancer
|
| 2019-10 |
Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea |
CANCER RESEARCH AND TREATMENT
|
| 2019-07 |
Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer |
RADIOTHERAPY AND ONCOLOGY
|
| 2019-05 |
Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer. |
EUROPEAN JOURNAL OF CANCER
|
| 2019-04 |
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial |
CANCER RESEARCH AND TREATMENT
|
| 2019-04 |
Clinical analysis of patients with skeletal metastasis of lung cancer. |
BMC CANCER
|
| 2019-02 |
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma. |
ONCOLOGY
|
| 2019-01 |
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial |
CANCER RESEARCH AND TREATMENT
|
| 2018-11 |
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy |
BMC CANCER
|
| 2018-11 |
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial. |
CLINICAL CANCER RESEARCH
|
| 2018-11 |
Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma |
YONSEI MEDICAL JOURNAL
|
| 2018-10 |
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. |
ANNALS OF SURGICAL ONCOLOGY
|
| 2018-08 |
Prognostic significance of preoperative CT findings in patients with advanced gastric cancer who underwent curative gastrectomy |
PLOS ONE
|
| 2018-05 |
A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy |
AAPS JOURNAL
|
| 2018-03 |
The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status |
GASTRIC CANCER
|
| 2018-02 |
Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. |
BMC CANCER
|
| 2018-01 |
Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea |
CANCER RESEARCH AND TREATMENT
|
| 2017-10 |
Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer |
CLINICAL & TRANSLATIONAL ONCOLOGY
|
| 2017-09 |
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer |
ONCOTARGET
|
| 2017-07 |
Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1 |
CANCER RESEARCH AND TREATMENT
|
| 2017-06 |
Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer |
BRITISH JOURNAL OF SURGERY
|
| 2017-06 |
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer |
ONCOTARGET
|
| 2017-06 |
Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma |
CANCER MEDICINE
|
| 2017-05 |
Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab. |
ONCOTARGET
|
| 2017-03 |
Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma |
APMIS
|
| 2016-09 |
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma |
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
|